• Dianthus Therapeutics EVP, Head of R&D Simrat Randhawa cut her stake to 4,000 shares on June 1, a Form 4 shows.
• She exercised stock options for 26,530 shares at prices from $8.44 to $22.07.
• She sold 26,530 shares at weighted average prices of $89.72, $90.72, $91.37.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001992260-26-000006), on June 02, 2026, and is solely responsible for the information contained therein.